Big Gain For Kala Pharmaceuticals, Inc.
Mon, Mar 09, 2020 at 05:30 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) jumped higher at $7.93, representing a gain of 26.3%. On Fri 06 Mar 20, KALA:NASDAQ hit a New 2-Week Intraday High of $6.67. The stock got featured on our News Catalysts scanner on Mon 09 Mar 20 at 09:02 AM in the 'BIOTECH' category. From Fri 21 Feb 20, the stock recorded 30.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- AIM ImmunoTech Inc. (AIM:NYSEMKT), 190.48%
- Spherix Incorporated (SPEX:NASDAQ), 96.34%
- VelocityShares Daily 2x VIX Short-Term ETN (TVIX:NASDAQ), 49.72%
- Novan, Inc. (NOVN:NASDAQ), 35.21%
- LightPath Technologies, Inc. (LPTH:NASDAQ), 27.42%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 26.27%
- VelocityShares VIX Short-Term ETN (VIIX:NASDAQ), 24.62%
- ProShares UltraPro Short QQQ (SQQQ:NASDAQ), 20.69%
- ProShares UltraPro Short Nasdaq Biotechnology (ZBIO:NASDAQ), 19.84%
- AutoWeb, Inc. (AUTO:NASDAQ), 19.44%